A good daily multivitamin, vitamin D (2,000 to 4,000 IU), and B12 promote energy and health
Because overall weight reduction with retatrutide is greater than with other GLP-1 therapies, the absolute loss of lean mass may also be more substantial, which could have important implications in older, frail, and other high-risk patient populations
Karlsson, T., Hadizadeh, F., Rask-Andersen, M., Johansson, & Ek, W
Tirzepatide Compounded Dual GLP-1/GIP Receptor Agonist A next-generation weight loss medication that targets two metabolic pathways, GLP-1 and GIP receptors, for enhanced appetite control, improved insulin sensitivity, and greater fat metabolism
Ozempic does not directly damage hair follicles
STEP UP Phase 3b Trial Results: Semaglutide 7.2 mg in Adults with Obesity